It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 | Hyderabad, Telangana, India | ActiveCrescent Medicaments Private Limited, a active private limited company, was established on 05 June 2017 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304TG2017PTC117548. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 31 professional, Its leadership includes Javeed Shaik (Whole-Time Director), Shaik Junaid (Director), Shaik Janimiya (Managing Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Crescent Towers, 4-7-11/4/C Raghavendra Ngr, Nacharam, Hyderabad, Telangana, 500076.
U24304TG2017PTC117548
117548
05 June 2017
₹5.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Crescent Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Javeed Shaik | Whole-Time Director | 05 Jun 2017 | Current |
| Shaik Junaid | Director | 18 Jan 2021 | Current |
| Shaik Janimiya | Managing Director | 05 Jun 2017 | Current |
| Shaik Thahera | Whole-Time Director | 05 Jun 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crescent Medicaments Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.07% decrease. The company also saw a substantial fall in profitability, with a 134.1% decrease in profit. The company's net worth dipped by a decrease of 5.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Crescent Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Crescent Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Crescent Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Crescent Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Crescent Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Shaik Junaid was appointed as a Director was appointed as a Director on 18 Jan 2021 & has been associated with this company since 4 years 11 months . was documented.
Javeed Shaik was appointed as a Whole-time director was appointed as a Whole-time director on 05 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
Shaik Janimiya was appointed as a Managing Director was appointed as a Managing Director on 05 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
The activity Shaik Thahera was appointed as a Whole-time director was appointed as a Whole-time director on 05 Jun 2017 & has been associated with this company since 8 years 6 months . was completed.
The CIN of Crescent Medicaments Private Limited is U24304TG2017PTC117548.
Crescent Medicaments Private Limited is headquartered at Crescent Towers, 4-7-11/4/C Raghavendra Ngr, Nacharam, Hyderabad, Telangana, 500076.
Crescent Medicaments Private Limited was incorporated on 05 June 2017.
The current directors of Crescent Medicaments Private Limited are
The primary industry of Crescent Medicaments Private Limited is Trade.
Crescent Medicaments Private Limited is unlisted.
The authorized capital of Crescent Medicaments Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Crescent Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX